Indicative listing context
Neuralink Stock Price (Pre-IPO)
Neuralink is private. The brain-computer interface company has never listed publicly, so there is no official Neuralink stock price. Segmara tracks an indicative pre-IPO reference mark for Neuralink, shown above with the date it was set, with a free email tracker.
Indicative private-market reference marks: not a quote and not an offer. Segmara does not sell, broker, or arrange share purchases.
SEGMARA PRO
Filing alerts for Neuralink
Segmara Pro: a weekly IPO brief plus SEC filing alerts for 60+ companies, including Neuralink, from automated EDGAR checks every weekday, posted in the members forum; 7-day free trial, then $15 a month (plus any applicable tax). Research only, no share sales.
When will Neuralink IPO? · Free Neuralink tracker · Read a free issue · See the IPO calendar
Neuralink round data and risk-adjusted context
Neuralink is a high-interest private company, but round analysis must account for clinical, regulatory, and long-duration development risk.
Official June 2025 raise
Reported pre-money valuation around the Series E
Neurotechnology timelines are not public-software timelines
| Stage | Date | Valuation / price signal | Why it matters |
|---|---|---|---|
| Seed / early | 2016-2021 | Formation and R&D phase | Early economics are not a reliable public retail dataset. |
| Series D | 2023 | Reported growth round | Useful mainly as a historical valuation reference. |
| Series E | June 2025 | $650M raise; reported ~$9B pre-money | The latest clear funding marker for private-share search intent. |
| IPO status | Current | No public Neuralink ticker | Buyers still need private-market access and a long risk horizon. |
Seed-to-IPO path
Illustrative completeness map. Longer bars mean stronger public data or more useful current pricing context, not lower risk.
Access vehicles filed with the SEC
Since 2025-06, 10 funds and single-purpose vehicles have filed a Regulation D offering under a name that references Neuralink. That count is a measure of how much secondary demand is routed through vehicles rather than through the company.
| Filed | Filer | Source |
|---|---|---|
| 2026-06-22 | TWE Neuralink SPV, LLC | SEC filing |
| 2026-01-26 | BP Neuralink LP | SEC filing |
| 2025-09-08 | Eagle VP Fund 2 Series Neuralink | SEC filing |
| 2025-08-20 | Neuralink Jun 2025 a Series of CGF2021 LLC | SEC filing |
| 2025-08-13 | Neuralink Jul 2025 a Series of CGF2021 LLC | SEC filing |
These filers are independent of Neuralink and of Segmara. A registered name references a company, it does not prove what the vehicle holds or on what terms.
AI-ready data summary
A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.
| Metric | Value | Context |
|---|---|---|
| Canonical route | /neuralink-stock-price | Stable URL path for AI and search extraction. |
| Article title | Neuralink Stock Price (Pre-IPO) | Main page topic. |
| Attached public sources | 4 | Number of citation links rendered at the bottom of the article. |
| Segmara listed companies | 51 | Live private-company listings in the public catalogue. |
| Priced listings | 37 | Catalogue listings with visible indicative or direct marks. |
| Listings without an indicative price | 14 | Catalogue listings where a public price is intentionally not invented. |
| Company | Neuralink | Named company covered by this page. |
| Symbol label | NEUR | Segmara display symbol; not a public stock ticker unless separately stated. |
| Sector | Biotechnology | Catalogue sector used for comparison and internal linking. |
| Listing structure | Indicative | How the listing is categorized on Segmara. |
| Segmara mark | $236.21/sh · as of August 14, 2026 | Visible listing mark, or no indicative price yet. |
| Sector peer count | 1 | Number of live Segmara listings in Biotechnology. |
| Structure peer count | 5 | Number of live Segmara listings categorized as Indicative. |
| Price rank | 10 of 37 | Ranked highest-to-lowest among Segmara listings with visible marks. |
| Price percentile | 76th | Percentile among visible Segmara catalogue marks. |
| Catalogue median mark | $92.58 | Median visible mark across priced Segmara listings. |
| Premium/discount to median | +155% | Difference between this listing mark and the catalogue median mark. |
Data fingerprint chart
| Stage | Timing | Price / valuation signal | Interpretation |
|---|---|---|---|
| Seed / early | 2016-2021 | Formation and R&D phase | Early economics are not a reliable public retail dataset. |
| Series D | 2023 | Reported growth round | Useful mainly as a historical valuation reference. |
| Series E | June 2025 | $650M raise; reported ~$9B pre-money | The latest clear funding marker for private-share search intent. |
| IPO status | Current | No public Neuralink ticker | Buyers still need private-market access and a long risk horizon. |
| Chart metric | Score | Interpretation |
|---|---|---|
| Listing price percentile | 76 / 100 | $236.21/sh · as of August 14, 2026 ranks 10 of 37 priced listings |
Analytical lens
Search intent
Searches like 'Neuralink Stock Price (Pre-IPO)' are research questions: what a filing or a company statement confirms, what has only been reported, and what is still unknown.
What counts as a listing step
For an IPO, the primary record is a registration statement filed with the securities regulator of the listing market, such as an S-1 or F-1 on SEC EDGAR for a US listing. Funding rounds, valuations and secondary-market prices are context, not listing steps.
Segmara role
Segmara is an independent research site. It does not sell, broker, or arrange share purchases, and nothing on this page is investment advice.
How a company reaches a US listing
The SEC filing trail
DraftThe company can first submit a draft registration statement (DRS) for confidential SEC review.
S-1 or F-1The registration statement goes public on SEC EDGAR: Form S-1, or Form F-1 for many foreign companies. A company that used a draft must file publicly at least 15 days before its roadshow.
AmendmentsS-1/A or F-1/A amendments answer SEC comments, and one of them adds the expected price range.
PricingOnce the SEC declares the registration effective, the company sets the price with its underwriters and files the final prospectus, usually a 424B4.
First tradeThe shares start trading on the exchange named in the prospectus, such as Nasdaq or the NYSE.
Sources: SEC, March 3, 2025 · Investor.gov, October 14, 2022 · Regulation S-K Item 501 · SEC Form F-1.
Neuralink on SEC EDGAR
Segmara Pro checks SEC EDGAR for Neuralink filings every weekday and posts an alert in the members forum when one of these public filings appears. You can also check yourself with EDGAR full-text search.
Key takeaways
- The indicative mark, valuation context, and sector percentile render live in the data summary below.
- Compare Neuralink with sector peers in the catalogue, then read the full access guide.
- Track the indicative price free by email. No card, no documents, no brokerage account.
Risk notes
- Private-company exposure can be illiquid, transfer-restricted, and hard to value.
- Indicative marks and reported valuations are orientation points, not executable quotes.
- Availability of any route can depend on jurisdiction, eligibility, structure, and approval.
Public source links
Related reviews
Questions
Can I buy shares through Segmara?
No. Segmara is an independent research site. Segmara does not sell, broker, or arrange share purchases.
What can I do on Segmara?
Read the research pages, follow indicative marks with the free tracker (email only), check the free IPO calendar, or subscribe to Segmara Pro for a weekly IPO brief.
Is Segmara affiliated with the named company or platform?
No. Segmara is not affiliated with Neuralink or any named issuer, affiliate, investor, underwriter, or platform referenced on this page.
What is Neuralink's stock price today?
Neuralink is private, so there is no official public stock price. Segmara publishes an indicative pre-IPO reference mark, shown in the data summary on this page. It is not a live exchange quote and not an offer to sell.
Is Neuralink publicly traded?
No. Neuralink has not held an IPO and its shares do not trade on any public exchange. Any price you see for Neuralink is an indicative private-market estimate.
What is Neuralink worth right now?
Public reporting tracks Neuralink's valuation through its private funding rounds. Segmara's indicative mark reflects private-market signals and is not a guaranteed value.
Can I buy Neuralink stock before the IPO?
Not through a public exchange, and Segmara does not sell, broker, or arrange purchases of Neuralink shares. You can track Neuralink's indicative price for free with Segmara's email tracker and read how pre-IPO access has historically worked.
How does Segmara calculate its indicative mark?
Segmara aggregates private-market signals such as secondary transactions and funding rounds, refreshed periodically. The mark is indicative only: not a live quote and not investment advice, and no liquidity is guaranteed.
Next step
Track Neuralink free.
Get the indicative Neuralink price by email. Free, email only. No card, no documents, no brokerage account.
Get the free Neuralink tracker